ARTICLE | Discovery & Translation
Translational trendspotting: a Distillery dive into neurology
Highlights include a new approach to the amyloid hypothesis, white space strategies for stroke and gene therapies
February 10, 2022 2:35 PM UTC
A new lever for the amyloid hypothesis, compounds for stroke and gene therapies are among the preclinical advances for neurological diseases covered in BioCentury’s Distillery.
The Distillery is a curated collection of top translational studies in the scientific literature that provides summaries of preclinical papers presenting interventions with disease-modifying effects, and identifying the labs behind the work and the status of their IP at the time of publication. ...